Changes
The global Veterinary Vaccines market ($4.23 Bn) accounted for around 20% of the total Vaccines market ($29.71 Bn) in 2010. It is expected to grow with a CAGR of 5.80% to reach the market size of $5.6 Bn by 2015. United States represents the largest market for Veterinary vaccines worldwide, with the market share of 46% and market size of $1.94 Bn in 2010. Porcine vaccines is the largest sub-segment in the Veterinary Vaccines market which is forecasted to grow to $1.32 Bn market by 2015 whereas Canine Vaccines is the fastest growing segment among all the sub-segments with the growth rate of 5.81%.
The top 3 players in the Veterinary Vaccines market are Pfizer, Merck and Sanofi-Aventis, based on the revenues they generated in the Animal Health Segment in 2010. The report contains the company profile of 8 major players in this segment, with focus on their Veterinary Vaccines market activities only. There have been 11 Mergers/Acquisitions in the Veterinary Vaccines market in the last two years (2009-2011), with Pfizer acquiring Wyeth being the largest aquisition based on the deal size and the value add, it brought to Pfizer in the Veterinary Vaccines market and its portfolio. This acquisition has been analyzed in the market report.
Based on the market analysis, R&D trends, future focus areas of the key players and transactional activities in this segment, trends for the future with key focus areas have been analyzed.
=Introduction=
Vaccination protects hundreds of millions of animals worldwide from disease and possibly death. Animals, just like humans, suffer from a range of infectious diseases. As veterinary medicine has advanced, prevention of disease has become a priority as healthy food comes from healthy animals. One of the best means of preventing disease is by creating immunity in the animal. This is usually achieved by vaccination.
